CXorf66
gene geneOn this page
Also known as RP11-35F15.2SGPX
Summary
CXorf66 (chromosome X open reading frame 66, HGNC:33743) is a protein-coding gene on chromosome Xq27.1, encoding Uncharacterized protein CXorf66 (Q5JRM2).
The protein encoded by this gene is predicted to be a type I membrane protein, however, its exact function is not known.
Source: NCBI Gene 347487 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 20 total
- MANE Select transcript:
NM_001013403
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33743 |
| Approved symbol | CXorf66 |
| Name | chromosome X open reading frame 66 |
| Location | Xq27.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RP11-35F15.2, SGPX |
| Ensembl gene | ENSG00000203933 |
| Ensembl biotype | protein_coding |
| Entrez | 347487 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000370540
RefSeq mRNA: 1 — MANE Select: NM_001013403
NM_001013403
CCDS: CCDS35411
Canonical transcript exons
ENST00000370540 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001452973 | 139955728 | 139956739 |
| ENSE00001452974 | 139958064 | 139958217 |
| ENSE00001452975 | 139965409 | 139965521 |
Expression profiles
Bgee: expression breadth broad, 12 present calls, max score 83.32.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0133 / max 10.0930, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200723 | 0.0133 | 4 |
Top tissues by expression
123 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.32 | gold quality |
| cerebellar vermis | UBERON:0004720 | 82.71 | gold quality |
| left testis | UBERON:0004533 | 80.07 | gold quality |
| testis | UBERON:0000473 | 79.97 | gold quality |
| right testis | UBERON:0004534 | 79.70 | gold quality |
| quadriceps femoris | UBERON:0001377 | 69.42 | gold quality |
| thymus | UBERON:0002370 | 61.19 | silver quality |
| liver | UBERON:0002107 | 42.23 | gold quality |
| right lobe of liver | UBERON:0001114 | 37.32 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.20 | gold quality |
| muscle tissue | UBERON:0002385 | 32.41 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.89 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| uterine cervix | UBERON:0000002 | 27.38 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| urinary bladder | UBERON:0001255 | 26.74 | gold quality |
| blood | UBERON:0000178 | 26.71 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| metanephros cortex | UBERON:0010533 | 26.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting CXorf66, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-5004-3P | 99.54 | 68.27 | 1371 |
| HSA-MIR-642A-5P | 99.51 | 65.10 | 1152 |
| HSA-MIR-5695 | 99.41 | 67.48 | 1047 |
| HSA-MIR-3614-5P | 99.30 | 65.25 | 837 |
| HSA-MIR-3145-3P | 98.85 | 69.07 | 2031 |
| HSA-MIR-216B-3P | 98.55 | 67.19 | 1223 |
| HSA-MIR-6757-5P | 98.08 | 65.50 | 724 |
| HSA-MIR-4715-5P | 97.62 | 67.47 | 506 |
| HSA-MIR-6892-5P | 97.27 | 68.60 | 847 |
| HSA-MIR-4259 | 95.68 | 65.25 | 582 |
| HSA-MIR-1281 | 92.96 | 65.73 | 260 |
Literature-anchored findings (GeneRIF, showing 1)
- The SGPX gene is a putative novel cancer biomarker. [Meta-analysis] (PMID:24709545)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gm7073 | ENSMUSG00000079583 |
| rattus_norvegicus | Cxhxorf66 | ENSRNOG00000037399 |
Protein
Protein identifiers
Uncharacterized protein CXorf66 — Q5JRM2 (reviewed: Q5JRM2)
All UniProt accessions (1): Q5JRM2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_001013421* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038873 | CXorf66 | Family |
UniProt features (14 total): compositionally biased region 4, region of interest 3, topological domain 2, signal peptide 1, chain 1, glycosylation site 1, sequence variant 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JRM2-F1 | 54.03 | 0.02 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 24
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
chrXq27, ZNF362_TARGET_GENES, MIR1290, MIR3145_3P, MIR1281
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
3707 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CXorf66 | DIPK2B | Q9H7Y0 | 506 |
| CXorf66 | HIGD1C | A8MV81 | 480 |
| CXorf66 | COQ5 | Q5HYK3 | 358 |
| CXorf66 | ATP11C | Q8NB49 | 351 |
| CXorf66 | FAU | P35544 | 350 |
| CXorf66 | YARS1 | P54577 | 350 |
| CXorf66 | RPS3 | P23396 | 349 |
| CXorf66 | RPLP1 | P05386 | 348 |
| CXorf66 | RPS3A | P33443 | 348 |
| CXorf66 | RPL5 | P46777 | 348 |
| CXorf66 | RPLP0 | P05388 | 348 |
| CXorf66 | RPS28 | P25112 | 348 |
| CXorf66 | EIF3G | O75821 | 347 |
| CXorf66 | RPS26 | P02383 | 347 |
| CXorf66 | RPL30 | P04645 | 347 |
| CXorf66 | VARS1 | P26640 | 347 |
IntAct
39 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EMD | CXorf66 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAT | CXorf66 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RTP2 | CXorf66 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASPH | CXorf66 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIPF6 | CXorf66 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXorf66 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| CXorf66 | RPRM | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP6 | CXorf66 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXorf66 | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX10 | CXorf66 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXorf66 | POMGNT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXorf66 | RTP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXorf66 | ERGIC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXorf66 | YIPF6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXorf66 | PRUNE1 | psi-mi:“MI:0915”(physical association) | 0.500 |
| CXorf66 | LRP4 | psi-mi:“MI:0914”(association) | 0.350 |
| CXorf66 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| CXorf66 | AQP6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CXorf66 | TMX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| STX10 | CXorf66 | psi-mi:“MI:0915”(physical association) | 0.000 |
| POMGNT1 | CXorf66 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CXorf66 | ERGIC3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (35): CXorf66 (Two-hybrid), CXorf66 (Two-hybrid), CXorf66 (Two-hybrid), CXorf66 (Two-hybrid), CXorf66 (Two-hybrid), CXorf66 (Two-hybrid), CXorf66 (Two-hybrid), CXorf66 (Two-hybrid), CXorf66 (Two-hybrid), CXorf66 (Two-hybrid), TMX2 (Two-hybrid), LAT (Two-hybrid), DSG4 (Affinity Capture-MS), TRIM29 (Affinity Capture-MS), ANKRD50 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GR13, A2AEY4, B0QZF7, B3SRR7, B3SRX3, H2KZ49, O13757, O49498, O74981, P04515, P17467, P18036, P18037, P19715, P23047, P34338, P34627, P35662, P35663, P40167, P46013, P52529, P52530, P70486, Q01030, Q03703, Q04003, Q06813, Q09280, Q09458, Q11114, Q12418, Q2YDJ5, Q32LB6, Q3ZK65, Q4QY64, Q4V7B4, Q5JRM2, Q5M948, Q5RCX3
Diamond homologs: Q2YDJ5, Q5JRM2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
20 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
421 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:139965406:TAC:T | donor_loss | 1.0000 |
| X:139965407:A:AC | donor_gain | 0.9900 |
| X:139965408:C:CC | donor_gain | 0.9900 |
| X:139958062:A:AC | donor_gain | 0.9800 |
| X:139958063:C:CC | donor_gain | 0.9800 |
| X:139958062:ACATT:A | donor_gain | 0.9700 |
| X:139958063:CATTC:C | donor_gain | 0.9700 |
| X:139959714:T:TA | donor_gain | 0.9700 |
| X:139956738:CC:C | acceptor_gain | 0.9600 |
| X:139956739:CC:C | acceptor_gain | 0.9600 |
| X:139965405:CTACC:C | donor_gain | 0.9600 |
| X:139965406:TACCT:T | donor_gain | 0.9600 |
| X:139958063:CATT:C | donor_gain | 0.9500 |
| X:139958151:A:AC | donor_gain | 0.9500 |
| X:139958152:C:CC | donor_gain | 0.9500 |
| X:139958144:A:AC | donor_gain | 0.9300 |
| X:139965407:AC:A | donor_gain | 0.9300 |
| X:139965408:CC:C | donor_gain | 0.9300 |
| X:139956737:ACCC:A | acceptor_loss | 0.9200 |
| X:139956738:CCCTG:C | acceptor_loss | 0.9200 |
| X:139956739:CCTGA:C | acceptor_loss | 0.9200 |
| X:139956741:T:G | acceptor_loss | 0.9200 |
| X:139958056:AAACT:A | donor_loss | 0.9000 |
| X:139958057:AACTT:A | donor_loss | 0.9000 |
| X:139958058:ACTT:A | donor_loss | 0.9000 |
| X:139958059:CT:C | donor_loss | 0.9000 |
| X:139958060:TTA:T | donor_loss | 0.9000 |
| X:139958061:T:TC | donor_loss | 0.9000 |
| X:139958062:A:C | donor_loss | 0.9000 |
| X:139958063:C:CA | donor_loss | 0.9000 |
AlphaMissense
2356 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:139958149:C:G | G53R | 0.907 |
| X:139958119:A:G | C63R | 0.857 |
| X:139958148:C:T | G53D | 0.797 |
| X:139958129:A:C | F59L | 0.770 |
| X:139958129:A:T | F59L | 0.770 |
| X:139958131:A:G | F59L | 0.770 |
| X:139958171:T:A | R45S | 0.744 |
| X:139958171:T:G | R45S | 0.744 |
| X:139965460:A:G | W13R | 0.742 |
| X:139965460:A:T | W13R | 0.742 |
| X:139965481:A:G | C6R | 0.742 |
| X:139958136:A:C | M57R | 0.721 |
| X:139956052:A:C | F310L | 0.720 |
| X:139956052:A:T | F310L | 0.720 |
| X:139956054:A:G | F310L | 0.720 |
| X:139965477:A:T | V7D | 0.715 |
| X:139965474:A:C | L8R | 0.696 |
| X:139958114:A:C | F64L | 0.693 |
| X:139958114:A:T | F64L | 0.693 |
| X:139958116:A:G | F64L | 0.693 |
| X:139958136:A:T | M57K | 0.690 |
| X:139958113:A:G | C65R | 0.658 |
| X:139965458:C:A | W13C | 0.649 |
| X:139965458:C:G | W13C | 0.649 |
| X:139956244:T:A | K246N | 0.642 |
| X:139956244:T:G | K246N | 0.642 |
| X:139965471:A:C | L9R | 0.642 |
| X:139958106:A:G | L67P | 0.634 |
| X:139958163:A:G | L48P | 0.632 |
| X:139958117:A:C | C63W | 0.620 |
dbSNP variants (sampled 300 via entrez): RS1000204301 (X:139958382 T>C), RS1000216228 (X:139967314 G>A), RS1000297835 (X:139964307 A>G), RS1000400541 (X:139957029 G>A), RS1000478437 (X:139966641 A>AAATT), RS1000501603 (X:139962735 G>A), RS1000635460 (X:139962408 T>A), RS1000730434 (X:139956180 G>A,T), RS1001232417 (X:139955669 G>A,C,T), RS1001263467 (X:139956062 G>A), RS1001478672 (X:139963795 A>G), RS1001569171 (X:139965166 A>G), RS1001846038 (X:139963431 A>G), RS1002115488 (X:139955530 T>C), RS1002651791 (X:139962841 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.